Cardiac Arrest Clinical Trial
Official title:
Predicting Neurological Outcome Following Out of Hospital Cardiac Arrest (OHCA) by Quantitative Measurement of Serial Serum Biomarkers of Brain Injury.
Few early prognostic indicators are currently available for patients' families and clinicians following out of hospital cardiac arrest (OHCA), and blood biomarkers may be of prognostic value in these cases. Brain tissue is highly dependent upon aerobic respiration, and oxygen deprivation result in irreversible neuronal cell injury. Peptides released into the blood by injured neuronal cells can be measured to estimate degree of injury, and potentially predict long term neurological outcome.
Aggressive treatment for patients with out-of-hospital cardiac arrest (OHCA) can result in
return of spontaneous circulation (ROSC). However, prognosis for these patients remains poor,
with low rates of survival to hospital admission and low rates of survival to hospital
discharge. Furthermore, due to the exquisite sensitivity to hypoxic injury of neural tissue
(dependent on aerobic respiration) relative to that of cardiac muscle, patients for whom ROSC
can be obtained often suffer devastating neurological injury, with potential poor long-term
neurological outcome. In some ischemic processes, for example, myocardial infarction, rapid
measurement of cardiac biomarkers (e.g. Troponin isoform) is invaluable to current diagnosis
and management. However, with regards to ischemic brain injury, there is currently no rapid,
definitive diagnostic test to prognosticate outcome in OHCA. Biomarkers measurable in blood
would have vital applications in prognosis and clinical research of neurological outcome in
OHCA.
Other groups have studied the neurological predictive values of biomarkers after OHCA. A
variety of proteins including S100B, neuron-specific enolase, and G-FAP, co-peptin, Tau,
neurofilament light/ heavy chain, and secretoneurin have been proposed as potential
biomarkers of neurological outcome at OHCA. Unfortunately, many of these have been shown to
have several drawbacks. For example, some lack specificity due to being released during
resuscitation (e.g., S100B is found extracerebrally in muscle, adipocytes, and chondrocytes,
creating a confounding factor in CA patients receiving chest compressions). Others have
lacked sufficient sensitivity in the prognosticating of neurological outcome (ref).
Furthermore, there is a paucity of human studies in cardiac arrest on newer biomarkers that
have been studied in other acute brain injury disease processes that could potentially serve
as candidate biomarkers predicting neurological outcome at post cardiac arrest hypoxic brain
injuries. Biomarkers such as UCH-L1, SBDP, and MBP have not been studied in a OHCA cohort.
The Investigator therefore propose a prospective, observational study in which the
investigator will incorporate a minimally invasive and minimal risk measurement of blood
biomarkers at time of ROSC. This would be done by drawing blood at ROSC (0-59mins), and
additional blood draws at hours 6, 12, 18, 24, 48, 72, and on day 4, 5, and 6. The
Investigator will then determine whether biomarker levels correlates with survival to
hospital admission, survival to hospital discharge, and functional neurologic outcome at
discharge and at 6 months. The Investigator intend to sample patients that present to the
emergency department with non-CA chest pain in our study as well, which will allow us to draw
stable inferences.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06048068 -
Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events
|
N/A | |
| Recruiting |
NCT05558228 -
Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
|
||
| Completed |
NCT03685383 -
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
|
N/A | |
| Completed |
NCT04619498 -
Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest
|
N/A | |
| Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Withdrawn |
NCT02352350 -
Lactate in Cardiac Arrest
|
N/A | |
| Completed |
NCT03024021 -
Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
|
||
| Completed |
NCT02247947 -
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
|
||
| Completed |
NCT02275234 -
Care After Resuscitation
|
||
| Completed |
NCT01936597 -
Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage
|
N/A | |
| Completed |
NCT01944605 -
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
|
N/A | |
| Completed |
NCT01972087 -
Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest
|
N/A | |
| Active, not recruiting |
NCT01239420 -
Norwegian Cardio-Respiratory Arrest Study
|
||
| Completed |
NCT01191736 -
Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice
|
N/A | |
| Completed |
NCT00880087 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial
|
N/A | |
| Completed |
NCT00878644 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial
|
Phase 3 | |
| Completed |
NCT00729794 -
Vasopressin, Epinephrine, and Steroids for Cardiac Arrest
|
Phase 3 | |
| Recruiting |
NCT00441753 -
Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
|
N/A | |
| Completed |
NCT00347477 -
Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest
|
Phase 3 |